ICU Medical, Incorporated  

(Public, NASDAQ:ICUI)   Watch this stock  
Find more results for ICUI
-1.15 (-0.74%)
After Hours: 153.60 0.00 (0.00%)
Mar 28, 4:38PM EDT  
NASDAQ real-time data - Disclaimer
Currency in USD
Range 152.75 - 154.65
52 week 97.24 - 159.95
Open 154.35
Vol / Avg. 131,512.00/151,468.00
Mkt cap 2.51B
P/E 41.84
Div/yield     -
EPS 3.67
Shares 16.34M
Beta 0.40
Inst. own 95%
Feb 1, 2017
Q4 2016 ICU Medical Inc Earnings Release (Estimated)
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '16) 2016
Net profit margin 9.94% 16.63%
Operating margin 14.39% 22.25%
EBITD margin - 31.13%
Return on average assets 5.48% 9.48%
Return on average equity 5.83% 10.17%
Employees 2,803 -
CDP Score - -


951 Calle Amanecer
United States - Map
+1-949-3662183 (Phone)
+1-949-3668368 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


ICU Medical, Inc. is engaged in the development, manufacturing and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company's product line includes needlefree connection devices, closed system transfer devices (CSTD), needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems. It operates through the segment, which is engaged in the development, manufacturing and sale of medical technologies used in infusion therapy, critical care and oncology applications. Its Infusion Therapy products include MicroClave and MicroClave Clear, Neutron, NanoClave, Clave and SwabCap. Its Critical Care products include Hemodynamic Monitoring Systems, Closed Blood Sampling and Conservation Systems, and Other Critical Care Products and Accessories. Its Oncology products include ChemoLock CSTD and components, ChemoClave CSTD and components and Diana hazardous drug compounding system.

Officers and directors

Vivek Jain Chairman of the Board, Chief Executive Officer
Age: 56
Bio & Compensation  - Reuters
Scott E. Lamb Chief Financial Officer
Age: 53
Bio & Compensation  - Reuters
Steven C. Riggs Vice President - Operations
Age: 57
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Alison D. Burcar Vice President, General Manager - Infusion Systems
Age: 43
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Tom McCall Vice President, General Manager - Critical Care
Age: 58
Bio & Compensation  - Reuters
Kevin J. Mcgrody Controller
Bio & Compensation  - Reuters
Douglas E. Giordano Director
Bio & Compensation  - Reuters
Elisha W. Finney Independent Director
Age: 55
Bio & Compensation  - Reuters
David C. Greenberg Independent Director
Age: 49
Bio & Compensation  - Reuters
Joseph R. Saucedo Independent Director
Age: 73
Bio & Compensation  - Reuters